BridgeBio Pharma, Inc. (BBIO)
NASDAQ: BBIO · Real-Time Price · USD
83.54
-2.01 (-2.35%)
Jul 29, 2026, 4:00 PM EDT - Market closed
BridgeBio Pharma Market Cap
BridgeBio Pharma has a market cap or net worth of $16.38 billion as of July 29, 2026. Its market cap has increased by 86.56% in one year.
Market Cap
16.38B
Enterprise Value
17.93B
1-Year Change
86.56%
Ranking
Category
Stock Price
$83.54
ChartMarket Cap Chart
Since June 27, 2019, BridgeBio Pharma's market cap has increased from $3.32B to $16.38B, an increase of 393.31%. That is a compound annual growth rate of 25.23%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 29, 2026 | 16.38B | 11.10% |
| Dec 31, 2025 | 14.74B | 184.24% |
| Dec 31, 2024 | 5.19B | -26.16% |
| Dec 29, 2023 | 7.02B | 516.56% |
| Dec 30, 2022 | 1.14B | -53.61% |
| Dec 31, 2021 | 2.46B | -71.83% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Jun 27, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BioNTech SE | 23.38B |
| Insmed | 22.57B |
| Moderna | 22.14B |
| Genmab | 17.86B |
| Ascendis Pharma | 16.77B |
| Jazz Pharmaceuticals | 16.14B |
| Exelixis | 14.20B |
| Madrigal Pharmaceuticals | 12.42B |